On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
56° Feels Like: 56°
Wind: NNW 7 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

PM Thunderstorms 77°

Tonight

Thunderstorms Early 52°

Tomorrow

Partly Cloudy 76°

Alerts

Galapagos says GSK starting trials of its new drug

BRUSSELS (Reuters) - Belgian biotech company Galapagos said on Tuesday that its partner GlaxoSmithKline (GSK) planned to start Phase II studies into a drug candidate to treat two auto-immune disorders.

Galapagos said in a statement that GSK would launch the studies for compound GSK2586184 in systemic lupus erythematosus (SLE) and chronic plaque psoriasis.

Galapagos is eligible to receive 34 million euros in additional milestones plus up to double-digit percentage royalties on global sales. It is the second selective JAK1 molecule discovered by Galapagos to enter Phase 2 studies.

(Reporting by Philip Blenkinsop)

Comments